Akademska digitalna zbirka SLovenije - logo
E-resources
Full text
Peer reviewed Open access
  • Coronavirus Disease 2019 Co...
    Bloch, Evan M; Goel, Ruchika; Zhu, Xianming; Patel, Eshan U; Shoham, Shmuel; Sullivan, David J; Gebo, Kelly A; Casadevall, Arturo; Tobian, Aaron A R

    Clinical infectious diseases, 07/2023, Volume: 77, Issue: 2
    Journal Article

    Abstract Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) use between October and December 2020 was characterized using the National Inpatient Sample database. CCP was administered in 18.0% of COVID-19-associated hospitalizations and was strongly associated with older age and increased disease severity. There were disparities in the receipt of CCP by race and ethnicity, geography, and insurance.